Showing results (261-270 of 419) with videos related to
Sort By:
Pageof 42
Blood|December 19, 2007
Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cellsBruno Delorme, Jochen Ringe, Nathalie Gallay, et al.Lancet (London, England)|August 25, 2004
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trialThomas J Schnitzer, Gerd R Burmester, Eduardo Mysler, et al.Acta Neuropathologica|April 17, 2021
Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathologyElise Siegert, Akinori Uruha, Hans-Hilmar Goebel, et al.International Journal of Molecular Sciences|August 9, 2018
CTLA-4 Mediates Inhibitory Function of Mesenchymal Stem/Stromal CellsTimo Gaber, Kerstin Schönbeck, Holger Hoff, et al.EULAR Rheumatology Open|June 29, 2026
Comparison of the PK, PD, safety, tolerability, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab in healthy Japanese males: a phase 1, randomised, crossover studyTomoko Hasunuma, Paul Emery, Ernest Choy, et al.Annals of the Rheumatic Diseases|March 6, 2012
Inflammation assessment in patients with arthritis using a novel in vivo fluorescence optical imaging technologyStephanie G Werner, Hans-Eckhard Langer, Sarah Ohrndorf, et al.Annals of the Rheumatic Diseases|November 19, 2016
Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trialGerd R Burmester, Yong Lin, Rahul Patel, et al.Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor InhibitorsRoy Fleischmann, Janet van Adelsberg, Yong Lin, et al.European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|August 5, 2003
Immunomodulation of tissue-engineered transplants: in vivo bone generation from methylprednisolone-stimulated chondrocytesAndreas Haisch, Frank Wanjura, Cornelia Radke, et al.Cloning and Stem Cells|February 7, 2009
Gene expression profile of multipotent mesenchymal stromal cells: Identification of pathways common to TGFbeta3/BMP2-induced chondrogenesisDominique Mrugala, Nadège Dossat, Jochen Ringe, et al.Pageof 42